Journals / Mikrobiyoloji Bülteni / 2007 / Cilt: 41 - Sayı: 4

Investigation of glycopeptid resistance in methicillin resistant staphylococcal isolates

Metisiline dirençli stafilokok izolatlarında glikopeptid direncinin araştırılması

Pages
511–516
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It can be concluded that, since agar screening method is not reliable for the detection of vancomycin resistance, further multi-center studies with the use of standard methods are needed in order to clarify the vancomycin resistance patterns of staphylococci in our country.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The emergence of Staphylococcus aureus strains with intermediate resistance (VISA) and heterogen resistance (hVISA) to vancomycin leads to the occurence of severe therapeutic problems.
📊
Key Findings & Data:A total of 120 staphyloccoccal strains (92 MRSA and 28 MRCoNS) isolated from different clinical specimens (tracheal aspirate, blood, abscess, wound swabs, sputum, catheter tips, etc) between the period of June 2005 to December 2006 were included to the study.
💡
Conclusion & Impact:It can be concluded that, since agar screening method is not reliable for the detection of vancomycin resistance, further multi-center studies with the use of standard methods are needed in order to clarify the vancomycin resistance patterns of staphylococci in our country.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

The emergence of Staphylococcus aureus strains with intermediate resistance (VISA) and heterogen resistance (hVISA) to vancomycin leads to the occurence of severe therapeutic problems. The aim of this study was to investigate the vancomycin resistance in methicillin resistant S.aureus (MRSA) and coagulase-negative staphylococci (MRCoNS) isolated from clinical samples in Bacteriology Laboratory of Microbiology and Clinical Microbiology Department of Celal Bayar University Faculty of Medicine, Manisa (located in western Anatolia, Turkey). A total of 120 staphyloccoccal strains (92 MRSA and 28 MRCoNS) isolated from different clinical specimens (tracheal aspirate, blood, abscess, wound swabs, sputum, catheter tips, etc) between the period of June 2005 to December 2006 were included to the study. Vancomycin resistance were determined by agar screening method using brain hearth infusion agar plates containing 6 μg/mL vancomycin. Standard E-test and macro E-test methods were performed for 17 (14%) staphylococcal strains (10 MRSA and 7 MRCoNS) which had grown in agar screening plates. Vancomycin and teicoplanin minimal inhibitory concentration (MIC) ranges of those strains were found as 1.5-4 μg/mL and 2-4 μg/mL, respectively, by standard E-test method. In our study, no VISA and hVISA isolates were detected when MIC value of ≥8 μg/mL for vancomycin and teicoplanin, or ≥12 μg/mL for teicoplanin only were accepted as the criteria for hVISA determination. Agar screening method which is preferably used in routine laboratories for practical and economical reasons, lower sensitivity and specificity than E-test. It can be concluded that, since agar screening method is not reliable for the detection of vancomycin resistance, further multi-center studies with the use of standard methods are needed in order to clarify the vancomycin resistance patterns of staphylococci in our country.

Özet

Günümüzde vankomisine orta düzeyde dirençli S.aureus (VISA) ve heterojen dirençli S.aureus (hVISA) suşlarının ortaya çıkmış olması tedavide büyük sorunlar yaratmaktadır. Bu çalışmada metisiline dirençli Staphylococcus aureus (MRSA) ve koagülaz-negatif stafilokok (MRKNS) klinik izolatlarında glikopeptid direncinin araştırılması amaçlanmıştır. Çalışmaya, Celal Bayar Üniversitesi Tıp Fakültesi Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dalı Bakteriyoloji Laboratuvarı’nda Haziran 2005-Aralık 2006 tarihleri arasında çeşitli klinik örneklerden (trakeal aspirat, kan, abse, yara sürüntüsü, balgam, kateter ucu, vb) izole edilen 120 stafilokok suşu (92 MRSA, 28 MRKNS) alınmıştır. Glikopeptid direnci 6 μg/mL vankomisin içeren beyin-kalp infüzyon agar plakları kullanılarak agar tarama testi ile araştırılmıştır. Agar tarama yöntemi ile elde edilen 17 (%14) stafilokok suşuna (10 MRSA, 7 MRKNS) standart E-test ve makro E-test yöntemi uygulanmıştır. Çalışmamızda, standart E-test yöntemiyle izolatların vankomisin minimum inhibisyon konsantrasyon (MİK) aralığı 1.5-4 μg/mL, teikoplanin MİK aralığı ise 2-4 μg/mL olarak bulunmuştur. Vankomisin ve teikoplanin MİK değerleri ≥8 μg/mL veya sadece teikoplanin MİK değeri ≥12 μg/mL olan suşlar hVISA olarak kabul edildiğinde, çalışmamızda VISA ve hVISA izolatına rastlanmamıştır. Sonuç olarak uygulama kolaylığı ve düşük maliyeti nedeniyle rutin laboratuvarlarda tercih edilen ancak özgüllük ve duyarlılığı E-test yöntemine göre oldukça düşük olan agar tarama yönteminin, vankomisin direncinin araştırılmasında güvenilir olmayabileceği ve ülkemizdeki stafilokok izolatlarında vankomisine direnç durumunun belirlenmesi için standart yöntemlerin kullanıldığı çok merkezli çalışmalara ihtiyaç olduğu düşünülmüştür.

🔖

Cite This Article

LİMONCU, M. H., ERMERTCAN, Ş., TAŞLI, H., KURUTEPE, S. (2007). Investigation of glycopeptid resistance in methicillin resistant staphylococcal isolates. Mikrobiyoloji Bülteni, Cilt: 41 - Sayı: 4, 511–516. https://ajindex.com/articles/299383

References (13)

  1. Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-3
  2. Nunes APF, Teixeira LM, Iorio NLP, et al. Heterogeneous resistance to vancomycin in Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening. Int J Antimicrob Agents 2006; 27: 307-15
  3. Sancak B, Erciş S, Menemenlioğlu D, Çolakoğlu Ş, Hasçelik G. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 2005; 56: 519-23
  4. Nakipoğlu Y, Derbentli Ş, Çağatay AA, Katrancı H. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish University Hospital. BMC Infect Dis 2005; 5: 1-8
  5. VISA/VRSA; Vancomycin-Intermediate/Resistant Staphylococcus aureus Laboratory Detection.
  6. Walsh TR, Bolmström A, Qwarnström A, et al. Evalution of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001; 39: 2439-44
  7. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-6
  8. Tenover FC, Lancaster MV, Hill BC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998; 36: 1020-7
  9. Avison MB, Bennett PM, Howe RA, Walsh TR. Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50. J Antimicrob Chemother 2002; 49: 255-60
  10. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin- United States. Morbidity Mortality Weekly Report (MMWR) 2002; 51: 565-7
  11. Yaygın YE. Metisiline dirençli Staphylococcus aureus kökenlerinde vankomisin direncinin araştırılması. Ege Üniversitesi Tıp Fakültesi, Mikrobiyoloji ve Klinik Mikrobiyoloji Anabilim Dalı Uzmanlık Tezi, İzmir, 2005
  12. Center KJ, Reboli AC, Hubler R, Rodgers GL, Long SS. Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri. J Clin Microbiol 2003; 41: 4660-5
  13. Hussain FM, Boyle-Vavra S, Shete PB, Daum RS. Evidence fo